COVID-19 coagulopathy, thrombosis, and bleeding - PubMed (original) (raw)
Comment
COVID-19 coagulopathy, thrombosis, and bleeding
Noel C Chan et al. Blood. 2020.
Abstract
In this issue of Blood, Al-Samkari et al expand our understanding of thrombosis and bleeding risks and their predictors in hospitalized patients with coronavirus disease 2019 (COVID-19).
Conflict of interest statement
Conflict-of-interest disclosure: The authors declare no competing financial interests.
Conflict-of-interest disclosure: The authors declare no competing financial interests.
Figures
Potential mechanism linking dysregulated inflammation and coagulation with thrombosis. SARS-CoV-2 infects respiratory epithelial cells by binding to the angiotensin-converting enzyme 2 (ACE-2) receptor. Shed virus elicits an inflammatory response, which can be maladaptive in some cases leading to a cytokine storm mediated by proinflammatory cytokines such as interleukin 1β (IL-1β), IL-2, IL-6, tumor necrosis factor (TNF), and granulocyte-macrophage colony-stimulating factor (GM-CSF). Proinflammatory cytokines and SARS-CoV-2 infection of the endothelium contribute to hypercoagulability by upregulation of procoagulants such as tissue factor (TF), P-selectin, factor VIII (FVIII), fibrinogen, and von Willebrand factor (vWF); downregulation of anticoagulants such as thrombomodulin (TM) and endothelial protein C receptor (EPCR); and modulation of fibrinolysis by increased expression of type 1 plasminogen activator inhibitor, and leukocyte recruitment. Finally, the hypoxia and immobility in hospitalized patients with COVID-19 are potent triggers of thrombosis. Illustration created with
BioRender.com
.
Comment on
- COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection.
Al-Samkari H, Karp Leaf RS, Dzik WH, Carlson JCT, Fogerty AE, Waheed A, Goodarzi K, Bendapudi PK, Bornikova L, Gupta S, Leaf DE, Kuter DJ, Rosovsky RP. Al-Samkari H, et al. Blood. 2020 Jul 23;136(4):489-500. doi: 10.1182/blood.2020006520. Blood. 2020. PMID: 32492712 Free PMC article. Clinical Trial.
Similar articles
- Coagulopathy and mesenteric ischaemia in severe SARS-CoV-2 infection.
English W, Banerjee S. English W, et al. ANZ J Surg. 2020 Sep;90(9):1826. doi: 10.1111/ans.16151. Epub 2020 Jul 13. ANZ J Surg. 2020. PMID: 32621375 Free PMC article. No abstract available. - COVID-19 associated coagulopathy: The crowning glory of thrombo-inflammation concept.
Gris JC, Perez-Martin A, Quéré I, Sotto A. Gris JC, et al. Anaesth Crit Care Pain Med. 2020 Jun;39(3):381-382. doi: 10.1016/j.accpm.2020.04.013. Epub 2020 May 4. Anaesth Crit Care Pain Med. 2020. PMID: 32418867 Free PMC article. No abstract available. - Understanding the COVID-19 coagulopathy spectrum.
Thachil J, Agarwal S. Thachil J, et al. Anaesthesia. 2020 Nov;75(11):1432-1436. doi: 10.1111/anae.15141. Epub 2020 Jun 15. Anaesthesia. 2020. PMID: 32437586 Free PMC article. No abstract available. - The coagulopathy, endotheliopathy, and vasculitis of COVID-19.
Iba T, Connors JM, Levy JH. Iba T, et al. Inflamm Res. 2020 Dec;69(12):1181-1189. doi: 10.1007/s00011-020-01401-6. Epub 2020 Sep 12. Inflamm Res. 2020. PMID: 32918567 Free PMC article. Review. - Viral infections and atherothrombosis: Another caution in the wake of COVID-19?
Pereira MP, Lima EG, Serrano Junior CV. Pereira MP, et al. Rev Assoc Med Bras (1992). 2020 Mar;66(3):366-369. doi: 10.1590/1806-9282.66.3.366. Rev Assoc Med Bras (1992). 2020. PMID: 32520159 Review. No abstract available.
Cited by
- Phenome-wide and expression quantitative trait locus associations of coronavirus disease 2019 genetic risk loci.
Moon CY, Schilder BM, Raj T, Huang KL. Moon CY, et al. iScience. 2021 Jun 25;24(6):102550. doi: 10.1016/j.isci.2021.102550. Epub 2021 May 18. iScience. 2021. PMID: 34027315 Free PMC article. - High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19.
Ripa M, Galli L, D'Angelo A, Apruzzi L, Palumbo D, Campochiaro C, Tassan Din C, Danise A, Da Prat V, Vitali G, Brugliera L, Poli A, Monardo R, Monti G, Baccellieri D, De Cobelli F, Clementi M, Iannaccone S, Dagna L, Rovere-Querini P, Ciceri F, Tresoldi M, Zangrillo A, Scarpellini P, Castagna A; COVID-BioB Study Group. Ripa M, et al. Open Forum Infect Dis. 2022 Sep 2;9(9):ofac454. doi: 10.1093/ofid/ofac454. eCollection 2022 Sep. Open Forum Infect Dis. 2022. PMID: 36168552 Free PMC article. - Coronavirus Disease 2019 and Pituitary Apoplexy: A Single-Center Case Series and Review of the Literature.
Martinez-Perez R, Kortz MW, Carroll BW, Duran D, Neill JS, Luzardo GD, Zachariah MA. Martinez-Perez R, et al. World Neurosurg. 2021 Aug;152:e678-e687. doi: 10.1016/j.wneu.2021.06.004. Epub 2021 Jun 12. World Neurosurg. 2021. PMID: 34129968 Free PMC article. Review. - D-dimer as a predictive and prognostic marker among COVID-19 patients.
Elkhalifa AME. Elkhalifa AME. Saudi Med J. 2022 Jul;43(7):723-729. doi: 10.15537/smj.2022.43.7.20220213. Saudi Med J. 2022. PMID: 35830989 Free PMC article. - Brain Pathology in COVID-19: Clinical Manifestations and Potential Mechanisms.
Xu Z, Wang H, Jiang S, Teng J, Zhou D, Chen Z, Wen C, Xu Z. Xu Z, et al. Neurosci Bull. 2024 Mar;40(3):383-400. doi: 10.1007/s12264-023-01110-0. Epub 2023 Sep 16. Neurosci Bull. 2024. PMID: 37715924 Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical